Farmacia e farmacoloxía

2019

1. 5-HT 2 receptor binding, functional activity and selectivity in N-benzyltryptamines

   PLoS ONE, Vol. 14, Núm. 1

2. 2-Aryladenine derivatives as a potent scaffold for A1, A3 and dual A1/A3 adenosine receptor antagonists: Synthesis and structure-activity relationships

   Bioorganic and Medicinal Chemistry, Vol. 27, Núm. 16, pp. 3551-3558

3. A New Model of Sensorial Neuron-Like Cells for HTS of Novel Analgesics for Neuropathic Pain

   SLAS Discovery, Vol. 24, Núm. 2, pp. 158-168

4. A multifunctional drug nanocarrier for efficient anticancer therapy

   Journal of Controlled Release, Vol. 294, pp. 154-164

5. A novel low molecular weight nanocomposite hydrogel formulation for intra-tumoural delivery of anti-cancer drugs

   International Journal of Pharmaceutics, Vol. 565, pp. 151-161

6. A prospective study of the clinical outcomes and prognosis associated with comorbid COPD in the atrial fibrillation population

   International Journal of COPD, Vol. 14, pp. 371-380

7. Ablation of atrial fibrillation in patients with Brugada syndrome: A systematic review of the literature

   Journal of Arrhythmia, Vol. 35, Núm. 1, pp. 18-24

8. Adherence to biological therapies in patients with chronic inflammatory arthropathies

   Farmacia Hospitalaria, Vol. 43, Núm. 4, pp. 134-139

9. Advanced glycation end-products disrupt human endothelial cells redox homeostasis: new insights into reactive oxygen species production

   Free Radical Research, Vol. 53, Núm. 2, pp. 150-169

10. Advances in Drug Delivery Strategies for Microbial Healthcare Products

    Environmental Chemistry for a Sustainable World, pp. 1-38

11. An Observational Study of the Efficacy and Safety of Voriconazole in a Real-Life Clinical Setting

    Journal of Chemotherapy, Vol. 31, Núm. 1, pp. 49-57

12. Anandamide-nanoformulation obtained by electrospraying for cardiovascular therapy

    International Journal of Pharmaceutics, Vol. 566, pp. 1-10

13. Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

    Therapeutic Advances in Gastroenterology, Vol. 12

14. Association of GSTP1 and ERCC1 polymorphisms with toxicity in locally advanced head and neck cancer platinum-based chemoradiotherapy treatment

    Head and Neck, Vol. 41, Núm. 8, pp. 2704-2715

15. Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: First single-centre, prospective, crossover study in patients

    International Journal of Pharmaceutics, Vol. 567

16. Bioinspired hydrogels for drug-eluting contact lenses

    Acta Biomaterialia, Vol. 84, pp. 49-62

17. Blood glutamate EAAT2-cell grabbing therapy in cerebral ischemia

    EBioMedicine, Vol. 39, pp. 118-131

18. Caniferolide A, a Macrolide from Streptomyces caniferus, Attenuates Neuroinflammation, Oxidative Stress, Amyloid-Beta, and Tau Pathology in Vitro

    Molecular Pharmaceutics, Vol. 16, Núm. 4, pp. 1456-1466

19. Co-delivery of RNAi and chemokine by polyarginine nanocapsules enables the modulation of myeloid-derived suppressor cells

    Journal of Controlled Release, Vol. 295, pp. 60-73

20. Conciliación de la medicación en el paciente crítico

    Proyecto Lumbre: Revista Multidisciplinar de Insuficiencia Cutánea Aguda, Mes 19, pp. 63-69